Value8 (VALUE) H2 2025 earnings summary

Executive summary

• Investment portfolio grew by 26.9% to €139.6 million, driven by increased stakes in Ctac, acquisition of Naviva Kraamzorg, and a new 5% stake in Knaus Tabbert AG.

• Net equity rose 15.7% to €119.2 million, with net asset value (NAV) per share up 14.7% to €11.31.

• Net profit more than doubled to €16.9 million from €7.1 million year-over-year.

• Dividend proposed at €0.21 per ordinary share, a 5% increase, and €0.3125 per preference C share.

• Audit issued an unqualified opinion, highlighting robust valuation processes and risk management.

Financial highlights

• Total operating income more than doubled to €20.4 million (2024: €9.6 million).

• Fair value increase of €17.4 million, mainly from listed interests and derivative instruments.

• Interest income was €1.1 million; dividend income halved to €1.8 million.

• Operating expenses rose to €2.3 million (2024: €1.9 million); financial expenses increased to €0.8 million.

• Earnings per share rose to €1.71 (2024: €0.71).

Outlook and guidance

• Continued focus on operational improvements and add-on acquisitions in 2026.

• Strong financial position supports potential for major investments and further NAV growth, though short-term results remain sensitive to market conditions.